Nephros, Inc.
NEPH
$3.58
$0.113.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.21% | -0.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.21% | -0.73% | |||
| Cost of Revenue | 12.75% | 6.44% | |||
| Gross Profit | 8.40% | -5.28% | |||
| SG&A Expenses | 8.85% | 3.90% | |||
| Depreciation & Amortization | -9.38% | -5.88% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.58% | 5.87% | |||
| Operating Income | 438.89% | -94.27% | |||
| Income Before Tax | 125.81% | -81.76% | |||
| Income Tax Expenses | -- | -100.00% | |||
| Earnings from Continuing Operations | 125.81% | -81.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 125.81% | -81.60% | |||
| EBIT | 438.89% | -94.27% | |||
| EBITDA | 148.00% | -85.63% | |||
| EPS Basic | 125.86% | -81.76% | |||
| Normalized Basic EPS | 127.78% | -82.00% | |||
| EPS Diluted | 72.41% | -80.67% | |||
| Normalized Diluted EPS | 128.57% | -81.77% | |||
| Average Basic Shares Outstanding | 0.03% | 0.33% | |||
| Average Diluted Shares Outstanding | -1.91% | 1.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||